eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiology

Sinus Node Dysfunction

Author: M Silvana Horenstein, MD, Associate in Pediatric and Fetal Cardiac Diagnostic, Diagnostico Gineco-Obstetrico, PC; Associate Director, Legacy Department, Best Doctors, Inc
Coauthor(s): Peter P Karpawich, MD, Professor of Pediatric Medicine, Department of Pediatrics (Cardiology), Wayne State University School of Medicine; Director, Cardiac Electrophysiology and Pacemaker Services, Children's Hospital of Michigan
Contributor Information and Disclosures

Updated: Jul 25, 2008

Introduction

Background

The sinus node (SN) is a subepicardial structure normally located in the right atrial wall near the superior vena cava entrance on the upper end of the sulcus terminalis. It is formed by a cluster of cells capable of spontaneous depolarization. Normally, these pacemaker cells depolarize at faster rates than any other latent cardiac pacemaker cell inside the heart. Therefore, a healthy SN directs the rate at which the heart beats. Electrical impulses generated in the SN must then be conducted outside the SN in order to depolarize the rest of the heart. SN activity is regulated by the autonomic nervous system. For example, parasympathetic stimulation causes sinus bradycardia, sinus pauses, or sinoatrial exit block. These actions decrease SN automaticity, thereby decreasing the heart rate.

Sympathetic stimulation on the other hand, increases the slope of phase 4 spontaneous depolarizations. This increases the automaticity of the SN, thereby increasing the heart rate. Blood supply to the SN is provided by the right coronary artery in most cases.

SN dysfunction (SND) constitutes an important cause of morbidity in patients who have undergone surgery for congenital heart disease (CHD). It is also commonly seen in elderly persons who have normal cardiac anatomy.

SND may manifest as abnormal SN impulse formation and/or propagation, which leads to rhythms that are slow (ie, bradyarrhythmias) or fast (ie, tachyarrhythmias) for the person's age. SND is referred to as "sick sinus syndrome" when the SND is accompanied by symptoms such as dizziness or syncope.

ECG criteria for SND apply to the presence of one or more of the following:

  • Sinus bradycardia below the heart rate expected for age (ie, <100 beats per minute [bpm] in an infant, <80 bpm in a preschool child, <60 bpm in a school child, <50 bpm in an adolescent)
  • Sinus pause or absence of an expected P wave for more than 3 seconds, which may be due to sinus arrest (failure of the SN pacemaker cells to depolarize) or due to sinoatrial exit block (depolarization of the SN but failure to conduct to the atria)
  • Slow escape rhythms that originate within the atria, His bundle, or ventricles
  • Marked sinus arrhythmia with constant variation in the P-P interval, which is likely to be accompanied by sinus bradycardia
  • Presence of both bradyarrhythmias and tachyarrhythmias (ie, SN reentry tachycardia, atrial tachycardias from an ectopic focus, atrial flutter, atrial fibrillation)

Classic electrophysiologic (EP) criteria for SND apply to the presence of one or more of the following:

  • Corrected SN recovery time (CSNRT) greater than 275 milliseconds
  • Sinoatrial conduction time greater than 200 milliseconds
  • Sinoatrial node arrest
  • Sinoatrial exit block
  • SN reentry tachycardia

However, the current recommendation is that the diagnosis should rely on noninvasive methods rather than measuring SN recovery time or sinoatrial conduction time in the EP laboratory because results can be normal despite the patient having symptoms of SND or vice versa. The most reliable noninvasive methods to diagnose SND are 24-hour Holter monitoring (which may show one or more of the ECG criteria already mentioned) and exercise testing (which may reveal chronotropic incompetence). 

Pathophysiology

The acquired form of SND may occur after damage to the SN artery during cardiac surgery or may be due to occlusion, such as after myocardial infarction. In the pediatric population SND and atrioventricular (AV) block have been found to occur more frequently in patients with Kawasaki disease with moderate to severe coronary artery disease than in the general population. This is believed to be secondary to myocarditis or abnormal microcirculation in the SN artery and the AV-node artery.1

The idiopathic form of SND is degenerative, with fibrosis and fatty infiltration of the SN and consequent decrease of functional nodal cells.

Clinical

History

In children with no structural heart anomalies, sinus node dysfunction (SND) is less common. These children are usually asymptomatic. Otherwise, they may report dizziness, fatigue, exercise intolerance, syncope, or shortness of breath with or without palpitations. Infants may present with poor feeding or easy fatigability, which may also be evident in toddlers and older children.

Physical

Older patients with SND and no structural congenital heart defects may be asymptomatic in general, despite being bradycardic for their age. Conversely, they may present with signs and symptoms of congestive heart failure (CHF), especially those who have undergone a Mustard operation for transposition of the great arteries or a Fontan operation for a single ventricle. Infants with CHF secondary to SND may be tachypneic and may have signs of pulmonary congestion on auscultation (ie, wheezing and rales) and hepatomegaly. In addition, they may show evidence of failure to thrive, with weight below the fifth percentile.

Causes

The etiology for most cases is unknown. Causes can be categorized as follows:

  • Nonsurgical causes
    • SND may be familial. An autosomal dominant pattern of inheritance has been described.
    • Emery-Dreifuss muscular dystrophy is an X-linked muscle disorder associated with SND and AV conduction defects. If AV conduction defects are present, sudden cardiac death may result unless treated with permanent pacing. Males and females may be affected with equal frequency.
    • SND may be idiopathic. However, this form is rarely seen in children, especially in those without CHD or previous heart surgery.
    • SND may be caused by CHD, independent of the effects of surgical procedures. Examples include sinus venosus atrial septal defect (ASD), Ebstein anomaly, and heterotaxy syndromes, particularly left atrial isomerism.
    • Inflammatory diseases (eg, myocarditis, pericarditis, rheumatic fever) can result in SND.
    • Animal models of congenital complete AV block have shown that maternal immunoglobulin G (IgG) inhibits SN pacemaker cells, as well as AV node cells.
    • SND results from inactivation of genes that code for units of channels that play a key role in the regulation of cardiac pacemaker activity:
      • Mutations in the cardiac ion channel gene SCN5A causes SND as well as other cardiac arrhythmias, including long QT syndrome, Brugada syndrome, idiopathic ventricular fibrillation, and progressive cardiac conduction disturbances.
      • Loss of function of a pacemaker channel that plays a key role in the automaticity of the SN has been associated with mutations in the HCN4 gene.
      • Animal studies have shown that increased expression of A(3)AR adenosine receptors in mice resulted in AV block and pronounced SND in vivo.2 Also, homozygous mutant mice with a defect of klotho gene expression (kl/kl) developed sudden death under stress, associated with SND (conduction block or arrest).
    • SND may be caused by CNS disease, which is usually secondary to increased intracranial pressure with subsequent increase in the parasympathetic tone.
    • SND may be secondary to antiarrhythmic drugs (eg, digitalis [because of SN exit block], propranolol, verapamil, quinidine, procainamide, lidocaine, disopyramide, reserpine).
    • Hypothyroidism may cause SND.
    • Hypothermia may cause temporary SND.
  • Surgical causes, especially with operations involving the right atrium (RA)
    • Gradual loss of sinus rhythm occurs after the Mustard, Senning, and all varieties of the Fontan operation. This is thought to be secondary to direct injury to the SN during surgery and also due to later chronic hemodynamic abnormalities. Paroxysmal atrial tachycardias are frequently associated with SND, and loss of sinus rhythm appears to increase the risk of sudden death. Patients with transposition of the great arteries now undergo the arterial switch operation, which avoids the extensive atrial suture lines that lead to SN damage.
    • SND was described in 15% of patients who had undergone the Ross operation for aortic valve disease or complex left-sided heart disease 2.6-11 years earlier.3 Other arrhythmias, such as complete AV block and ventricular tachycardia, were present as well after the Ross operation.
    • When repairing ASDs, especially sinus venosus ASDs, SND frequently occurs because of the proximity of the defect with SN tissue.
    • Patients who have undergone surgery for endocardial cushion defects (ECDs) may also have SND later.
    • SND may be caused by a Blalock-Hanlon atrial septectomy.
    • SND may occur after repair of partial anomalous pulmonary venous return (PAPVR) or total anomalous pulmonary venous return (TAPVR).
    • Cannulation of the superior vena cava (SVC), usually performed for cardiopulmonary bypass or extracorporeal membrane oxygenation (ECMO), may damage SN tissue.
    • Ischemic cardiac arrest may cause SND.

More on Sinus Node Dysfunction

Overview: Sinus Node Dysfunction
Differential Diagnoses & Workup: Sinus Node Dysfunction
Treatment & Medication: Sinus Node Dysfunction
Follow-up: Sinus Node Dysfunction
Multimedia: Sinus Node Dysfunction
References

References

  1. Sumitomo N, Karasawa K, Taniguchi K, et al. Association of sinus node dysfunction, atrioventricular node conduction abnormality and ventricular arrhythmia in patients with Kawasaki disease and coronary involvement. Circ J. Feb 2008;72(2):274-80. [Medline].

  2. Fabritz L, Kirchhof P, Fortmuller L, et al. Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors. Cardiovasc Res. Jun 1 2004;62(3):500-8. [Medline].

  3. Pasquali SK, Marino BS, Kaltman JR, et al. Rhythm and conduction disturbances at midterm follow-up after the ross procedure in infants, children, and young adults. Ann Thorac Surg. Jun 2008;85(6):2072-8. [Medline].

  4. Drago F, Silvetti MS, Grutter G, De Santis A. Long term management of atrial arrhythmias in young patients with sick sinus syndrome undergoing early operation to correct congenital heart disease. Europace. Jul 2006;8(7):488-94. [Medline].

  5. Silvetti MS, De Santis A, Marcora S, De Santo T, Grovale N, Drago F. Circadian pattern of atrial pacing threshold in the young. Europace. Feb 2008;10(2):147-50. [Medline].

  6. Shah MJ, Nehgme R, Carboni M, Murphy JD. Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the fontan procedure. Pacing Clin Electrophysiol. Jul 2004;27(7):949-54. [Medline].

  7. Ben Ameur Y, Smiri Z, Malek S, et al. Sinus node dysfunction after complete correction of tetralogy of Fallot. Report of a case. Arch Mal Coeur Vaiss. Dec 1998;91(12):1519-23. [Medline].

  8. Brembilla-Perrot B, Beurrier D, Houriez P, et al. Utility of transesophageal atrial pacing in the diagnostic evaluation of patients with unexplained syncope associated or not with palpitations. Int J Cardiol. Sep 2004;96(3):347-53. [Medline].

  9. Fish FA, Benson W. Disorders of cardiac rhythm and conduction. In: Moss and Adam's Heart Disease in Infants, Children and Adolescents. Vol 1. Philadelphia, PA: Lippincott Williams and Wilkins; 2000:495-6.

  10. Gaynor JW. Management of sinus venosus defects. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006;35-9. [Medline].

  11. Hasselman T, Schneider D, Madan N, Jacobs M. Reversal of fenestration flow during ventricular systole in Fontan patients in junctional or ventricular paced rhythm. Pediatr Cardiol. Sep-Oct 2005;26(5):638-41. [Medline].

  12. Hu K, Qu Y, Yue Y, Boutjdir M. Functional basis of sinus bradycardia in congenital heart block. Circ Res. Mar 5 2004;94(4):e32-8. [Medline][Full Text].

  13. Jose AD. Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am J Cardiol. Sep 1966;18(3):476-8. [Medline].

  14. Kugler JD. Sinoatrial node dysfunction. In: Gillette PC, Garson A Jr, eds. Pediatric Cardiac Dysrhythmias. New York, NY: Grune and Stratton; 1981:265-93.

  15. Kusumoto FM, Goldschlager N. Device therapy for cardiac arrhythmias. JAMA. Apr 10 2002;287(14):1848-52. [Medline].

  16. Morita H, Fukushima-Kusano K, Nagase S, et al. Sinus node function in patients with Brugada-type ECG. Circ J. May 2004;68(5):473-6. [Medline].

  17. Numata T, Abe H, Terao T, Nakashima Y. Possible involvement of hypothyroidism as a cause of lithium-induced sinus node dysfunction. Pacing Clin Electrophysiol. Jun 1999;22(6 Pt 1):954-7. [Medline].

  18. Sanders P, Morton JB, Kistler PM, et al. Electrophysiological and electroanatomic characterization of the atria in sinus node disease: evidence of diffuse atrial remodeling. Circulation. Mar 30 2004;109(12):1514-22. [Medline][Full Text].

  19. Smerup M, Hjertholm T, Johnsen SP, et al. Pacemaker implantation after congenital heart surgery: risk and prognosis in a population-based follow-up study. Eur J Cardiothorac Surg. Jul 2005;28(1):61-8. [Medline].

  20. Stieber J, Hofmann F, Ludwig A. Pacemaker channels and sinus node arrhythmia. Trends Cardiovasc Med. Jan 2004;14(1):23-8. [Medline].

  21. Takeshita K, Fujimori T, Kurotaki Y, et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation. Apr 13 2004;109(14):1776-82. [Medline][Full Text].

  22. Ueda K, Nakamura K, Hayashi T, et al. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J Biol Chem. Jun 25 2004;279(26):27194-8. [Medline][Full Text].

  23. Vetter VL, Tanner CS, Horowitz LN. Electrophysiologic consequences of the Mustard repair of d-transposition of the great arteries. J Am Coll Cardiol. Dec 1987;10(6):1265-73. [Medline].

  24. Vytopil M, Vohanka S, Vlasinova J, et al. The screening for X-linked Emery-Dreifuss muscular dystrophy amongst young patients with idiopathic heart conduction system disease treated by a pacemaker implant. Eur J Neurol. Aug 2004;11(8):531-4. [Medline].

  25. Warner KG, Halpin DP, Berul CI, Payne DD. Placement of a permanent epicardial pacemaker in children using a subcostal approach. Ann Thorac Surg. Jul 1999;68(1):173-5. [Medline].

Further Reading

Keywords

sinus node dysfunction, sinoatrial node dysfunction, SND, sick sinus syndrome, sinoatrial node disease, bradydysrhythmia, tachydysrhythmia, sinus bradycardia, sinus pauses, sinoatrial exit block, congenital heart disease, sinus arrest, atrial flutter, atrial fibrillation, myocarditis, congestive heart failure, CHF, Mustard operation, Fontan operation, Emery-Dreifuss muscular dystrophy, AV conduction defect, sudden cardiac death, sinus venosus atrial septal defect, ASD, Ebstein anomaly, heterotaxy syndromes, left atrial isomerism, pericarditis, rheumatic fever, long QT syndrome, Brugada syndrome, idiopathic ventricular fibrillation, progressive cardiac conduction disturbances, hypothyroidism, hypothermia, transposition of the great arteries, Ross operation, aortic valve disease, endocardial cushion defect, Blalock-Hanlon atrial septectomy, partial anomalous pulmonary venous return, PAPVR, total anomalous pulmonary venous return, TAPVR, ischemic cardiac arrest

Contributor Information and Disclosures

Author

M Silvana Horenstein, MD, Associate in Pediatric and Fetal Cardiac Diagnostic, Diagnostico Gineco-Obstetrico, PC; Associate Director, Legacy Department, Best Doctors, Inc
M Silvana Horenstein, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, and American Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Peter P Karpawich, MD, Professor of Pediatric Medicine, Department of Pediatrics (Cardiology), Wayne State University School of Medicine; Director, Cardiac Electrophysiology and Pacemaker Services, Children's Hospital of Michigan
Peter P Karpawich, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, Heart Rhythm Society, and Michigan State Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Paul M Seib, MD, Associate Professor of Pediatrics, University of Arkansas for Medical Sciences; Medical Director, Cardiac Catheterization Laboratory, Co-Medical Director, Cardiovascular Intensive Care Unit, Arkansas Children's Hospital
Paul M Seib, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, Arkansas Medical Society, International Society for Heart and Lung Transplantation, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

John W Moore, MD, MPH, Professor of Clinical Pediatrics, Division of Pediatric Cardiology, Mattel Children's Hospital of University of California at Los Angeles
John W Moore, MD, MPH is a member of the following medical societies: Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

CME Editor

Gilbert Herzberg, MD, Assistant Professor, Department of Pediatrics, Section of Pediatric Cardiology, New York Medical College
Gilbert Herzberg, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Chief Editor

Stuart Berger, MD, Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin
Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.